Skip to content

Study · Not a test of the peptide alone · 1992

1 result

[The effect of therapy with cytostatics and immunomodulators on mitotic pathology in Lewis tumor cells in mice].

Potapov IuN, Krutova TV, Pashkova VS, Khaleev DV

Izvestiia Akademii nauk SSSR. Seriia biologicheskaia1 Sept 1992

PMID1447424 (opens in a new tab)PepBankPUB-01447424
Publisher pageAsk about this study
Jump to 1 result

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

No result from this study comes from a test of the peptide.

Studies that did not test the peptide alone1

In this study, Thymalin was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking Thymalin.

  1. 01AnimalNot a test of Thymalin aloneAnimal study (in vivo)Mechanism

    In mice with Lewis tumours, pooled immunomodulators including thymalin differently affected the cytostatic activity of antitumour agents.

    In plain wordsIn mice with Lewis tumours, pooled immunomodulators including thymalin had different effects on the activity of antitumour agents.

    Peptide
    Thymalin
    Outcome
    Direction not reportedModification of cytostatic activity
    Study

    mousen: not reported in source

    Lewis tumour
    Outcome group
    Tumor growth · Cancer

    Source sentences

    Summary
    Immunomodulators differently affected the cytostatic activity of antitumour agents that may be associated with their mechanisms of action.
    1 context sentence
    Summary · context
    The effect of cytostatics (methylnitrosourea and methotrexate), immunomodulators (thymalin and reaferon) and their combinations on the mitotic pathology of mice Lewis tumour cells was studied.

    In this study, Thymalin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Thymalin.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    14 Oct 2026, 05:02 UTC

    Study results updated

  2. Version 1

    14 Oct 2026, 01:46 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.